共 151 条
[21]
Tavazzi L(2008)Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme Eur Heart J 29 2641-7
[22]
Latini R(2018)Skeletal muscle wasting in chronic heart failure ESC Heart Fail 5 1099-31
[23]
Alagiakrishnan K(2009)Perils of weight loss: the advantage of being obese in patients with heart failure Expert Rev Cardiovasc Ther 7 263-36
[24]
Banach M(2016)Prevalence, Profile, and Prognosis of Severe Obesity in Contemporary Hospitalized Heart Failure Trial Populations JACC Heart Fail 4 923-72
[25]
Ahmed A(2007)Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program Circulation 116 627-55
[26]
Aronow WS(1992)Prevalence of obesity: a comparative survey in France, the United Kingdom and the United States Int J Obes Relat Metab Disord 16 565-414
[27]
Cicoira M(2014)The obesity paradox in men with coronary heart disease and heart failure: the role of muscle mass and leptin Int J Cardiol 171 49-13
[28]
Bolger AP(2014)Obesity and the obesity paradox in heart failure Prog Cardiovasc Dis 56 409-35
[29]
Doehner W(2015)Impact of cardiorespiratory fitness on the obesity paradox in patients with systolic heart failure Am J Cardiol 115 209-200
[30]
Rauchhaus M(2015)Serum albumin and muscle measures in a cohort of healthy young and old participants Age 37 88-undefined